Nature Chemical Biology 2023

7 papers
In 2023, research published in Nature Chemical Biology focused on structural biology, G protein-coupled receptor (GPCR) signaling, and the application of computational methods in drug discovery. A primary theme involved the molecular mechanisms of receptor function, with studies detailing the structural basis of ligand selectivity and the signaling pathways of complement receptors C3aR and C5aR1. Investigations into the relaxin receptor RXFP1 further characterized its signaling through autoinhibition mechanisms. The year's edition also featured work on the chemical properties of biomolecular condensates, exploring how their internal environments affect biological function. The use of artificial intelligence was a prominent trend, exemplified by the identification of a new antibiotic through machine learning. Prolific contributors included Arthur Christopoulos, Patrick M. Sexton, and Alexander S. Powers. Collectively, these papers reflect a research landscape emphasizing the intersection of structural analysis, cellular signaling, and AI-driven therapeutic identification.

Top Research Directions

The 5 research directions with Nature Chemical Biology 2023 papers, ranked by paper count, next to 2022. Share is the fraction of the edition’s papers in the direction.

#Direction20232022Share 2023Share 20222022 rank
1Measuring Transcriptional Activity with Dual Luciferase Assays1014.3%0.0%—
2Modeling Molecular Dynamics Beyond Static Structural Snapshots1014.3%0.0%—
3Structural Basis of Receptor Subtype and Effector Selectivity1014.3%0.0%—
4Structural Determinants of Receptor Subtype Selectivity1014.3%0.0%—
5Template-Based Protein Structure Prediction1014.3%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Nature Chemical Biology 2023 papers: a paper credits every institution named in its affiliations, once. 9 institutions share 2 credited papers.

#InstitutionPapersShare20222022 rank
1043wmc583 150.0%0—
2Centre National de la Recherche Scientifique 150.0%0—
3Harvard Medical School 150.0%0—
4Harvard University 150.0%0—
5Inserm 150.0%0—
6Monash University 150.0%0—
7Stanford Medicine 150.0%0—
8Stanford University 150.0%0—
9Université de Montpellier 150.0%0—

Download all institutions as CSV

About this data

Papers. Nature Chemical Biology 2023 lists 7 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2022 use shares, since the edition went from 8 to 7 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 2 of 7 papers (28.6%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Nature Chemical Biology 2023”, https://lacuna.tiptreesystems.com/venue/nature-chemical-biology/2023.

Papers

Title
Antibiotic identified by AI
Author Correction: Distinct chemical environments in biomolecular condensates
Author Correction: Structural basis of efficacy-driven ligand selectivity at GPCRs
Distinct chemical environments in biomolecular condensates
Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins
Structural basis of efficacy-driven ligand selectivity at GPCRs
The relaxin receptor RXFP1 signals through a mechanism of autoinhibition